Stefan Suciu
European Organisation for Research and Treatment of Cancer(BE)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Cutaneous Melanoma Detection and Management, Childhood Cancer Survivors' Quality of Life, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma(2018)1,816 cited
- → Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy(2016)1,305 cited
- → Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial(2015)1,248 cited
- → Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial(2008)642 cited
- → Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group(2011)547 cited
- →